DK1185691T3 - Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf - Google Patents
Genomiske neisseriasekvenser og fremgangmåder til anvendelse derafInfo
- Publication number
- DK1185691T3 DK1185691T3 DK00910392T DK00910392T DK1185691T3 DK 1185691 T3 DK1185691 T3 DK 1185691T3 DK 00910392 T DK00910392 T DK 00910392T DK 00910392 T DK00910392 T DK 00910392T DK 1185691 T3 DK1185691 T3 DK 1185691T3
- Authority
- DK
- Denmark
- Prior art keywords
- sequences
- genomic
- neonatal
- methods
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13206899P | 1999-04-30 | 1999-04-30 | |
PCT/US1999/023573 WO2000022430A2 (en) | 1998-10-09 | 1999-10-08 | Neisseria genomic sequences and methods of their use |
GB0004695A GB0004695D0 (en) | 2000-02-28 | 2000-02-28 | Protein expression |
PCT/US2000/005928 WO2000066791A1 (en) | 1999-04-30 | 2000-03-08 | Neisseria genomic sequences and methods of their use |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1185691T3 true DK1185691T3 (da) | 2009-06-22 |
Family
ID=27255563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00910392T DK1185691T3 (da) | 1999-04-30 | 2000-03-08 | Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070219347A1 (de) |
EP (2) | EP1605061A1 (de) |
JP (1) | JP2003527079A (de) |
CN (2) | CN101033467A (de) |
AT (1) | ATE430207T1 (de) |
AU (1) | AU780308B2 (de) |
BR (1) | BR0010361A (de) |
CA (1) | CA2371032A1 (de) |
DE (1) | DE60042114D1 (de) |
DK (1) | DK1185691T3 (de) |
ES (1) | ES2323845T3 (de) |
MX (1) | MXPA01011047A (de) |
WO (1) | WO2000066791A1 (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998012332A1 (en) | 1996-09-17 | 1998-03-26 | Chiron Corporation | Compositions and methods for treating intracellular diseases |
CN101293920B (zh) | 1998-05-01 | 2012-07-18 | 诺华疫苗和诊断公司 | 脑膜炎奈瑟球菌抗原和组合物 |
CA2360667A1 (en) | 1999-01-22 | 2000-07-27 | Smithkline Beecham Biologicals S.A. | Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof |
EP2163628A3 (de) | 1999-03-12 | 2010-06-02 | GlaxoSmithKline Biologicals S.A. | Antigene Polypeptide aus Neisseria Meningitidis, dafür kodierende Polynukleotide und entsprechende schützende Antikörper |
BR0010130A (pt) | 1999-04-30 | 2002-06-04 | Chiron Spa | Antìgenos de neisseria conservados |
EP1179072A2 (de) | 1999-05-19 | 2002-02-13 | Chiron S.P.A. | Neisseria kombinationszusammensetzung |
MXPA02004283A (es) | 1999-10-29 | 2002-10-17 | Chiron Spa | Peptidos antigenicos neisseriales. |
GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
BRPI0107679B8 (pt) | 2000-01-17 | 2021-05-25 | Chiron Spa | composição compreendendo vesículas de membrana externa do grupo sérico b de neisseria meningitidis e um componente inorgânico e uso da mesma |
EP1252182B1 (de) | 2000-01-25 | 2012-06-20 | The University Of Queensland | KONSERVIERTE REGIONEN DES NEISSERIA MENINGITIDIS OBERFLÄCHENANTIGENS NhhA ENTHALTENDE PROTEINE |
ATE352631T1 (de) | 2000-02-28 | 2007-02-15 | Novartis Vaccines & Diagnostic | Heterologe expression von neisseria proteine |
GB0011108D0 (en) * | 2000-05-08 | 2000-06-28 | Microscience Ltd | Virulence gene and protein and their use |
KR20030024811A (ko) | 2000-07-27 | 2003-03-26 | 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 | 나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신 |
GB0107219D0 (en) * | 2001-03-22 | 2001-05-16 | Microbiological Res Authority | Immunogenic commensal neisseria sequences |
GB0108024D0 (en) * | 2001-03-30 | 2001-05-23 | Chiron Spa | Bacterial toxins |
CU23245A1 (es) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
BR0211494A (pt) | 2001-07-27 | 2004-08-17 | Chiron Srl | Adesinas de meningococo nada, app e orf 40 |
GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
EP1495039A4 (de) | 2002-03-20 | 2006-07-26 | Univ Emory | Neisseria-mutanten, lipooligosaccharide und immunogene zusammensetzungen |
KR101140033B1 (ko) * | 2002-08-02 | 2012-05-07 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 항원 조합물을 포함하는 나이세리아 백신 조성물 |
US7785608B2 (en) | 2002-08-30 | 2010-08-31 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
DE60335477D1 (de) | 2002-10-11 | 2011-02-03 | Novartis Vaccines & Diagnostic | Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien |
US7807802B2 (en) | 2002-11-12 | 2010-10-05 | Abbott Lab | Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
CN102302776B (zh) * | 2003-01-30 | 2014-06-18 | 诺华疫苗和诊断有限公司 | 抗多种脑膜炎球菌血清组的可注射性疫苗 |
CU23237A1 (es) | 2003-12-03 | 2007-09-26 | Ct Ingenieria Genetica Biotech | PROTEINA NMB1125 Y SU USO EN FORMULACIONES FARMACéUTICAS |
GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
EP1855715B1 (de) | 2005-01-27 | 2013-03-13 | Children's Hospital & Research Center at Oakland | Gna1870-basierte vesikelimpfstoffe für breitbandschutz gegen neisseria meningitidis-bedingte erkrankungen |
EP2351772B1 (de) | 2005-02-18 | 2016-07-13 | GlaxoSmithKline Biologicals SA | Proteine und Nukleinsäuren von meningitis-/sepsis-assoziierten Escherichia coli |
NZ599345A (en) | 2005-02-18 | 2013-07-26 | Novartis Vaccines & Diagnostic | Immunogens from uropathogenic Escherichia Coli |
US8119385B2 (en) * | 2005-03-04 | 2012-02-21 | Bp Corporation North America Inc. | Nucleic acids and proteins and methods for making and using them |
CU23578A1 (es) | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal |
GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
CU23549A1 (es) * | 2005-12-29 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Composiciones farmacéuticas que contienen la proteína nma0939 |
BRPI0713904A2 (pt) | 2006-06-29 | 2013-06-25 | Novartis Ag | polipeptÍdeos a partir de neisseria meningitidis |
US20100166788A1 (en) | 2006-08-16 | 2010-07-01 | Novartis Vaccines And Diagnostics | Immunogens from uropathogenic escherichia coli |
CU23630A1 (es) | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae |
AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
TW200902708A (en) | 2007-04-23 | 2009-01-16 | Wyeth Corp | Methods of protein production using anti-senescence compounds |
GB0713880D0 (en) | 2007-07-17 | 2007-08-29 | Novartis Ag | Conjugate purification |
EP2245048B1 (de) | 2008-02-21 | 2014-12-31 | Novartis AG | Meningokokken-fhbp-polypeptide |
EP2411048B1 (de) | 2009-03-24 | 2020-05-06 | GlaxoSmithKline Biologicals SA | Adjuvantierendes meningokokken-faktor-h-bindungsprotein |
AU2010247252A1 (en) | 2009-05-14 | 2012-01-12 | Sanofi Pasteur | Method for admixing the lipopolysaccharide (LPS) of gram-negative bacteria |
WO2011161653A1 (en) | 2010-06-25 | 2011-12-29 | Novartis Ag | Combinations of meningococcal factor h binding proteins |
CA2808975C (en) | 2010-08-23 | 2018-10-30 | Wyeth Llc | Stable formulations of neisseria meningitidis rlp2086 antigens |
JP5976652B2 (ja) | 2010-09-10 | 2016-08-24 | ワイス・エルエルシー | 髄膜炎菌orf2086抗原の非脂質化変異体 |
AU2011300418B2 (en) | 2010-09-10 | 2016-05-12 | Glaxosmithkline Biologicals Sa | Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom |
CN104334187B (zh) | 2012-03-09 | 2017-04-05 | 辉瑞公司 | 脑膜炎双球菌组合物及其方法 |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
CA2876138C (en) | 2012-06-14 | 2023-09-19 | Novartis Ag | Vaccines for serogroup x meningococcus |
US10000545B2 (en) | 2012-07-27 | 2018-06-19 | Institut National De La Sante Et De La Recherche Medicale | CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endothelia |
JP6446377B2 (ja) | 2013-03-08 | 2018-12-26 | ファイザー・インク | 免疫原性融合ポリペプチド |
WO2015033251A2 (en) | 2013-09-08 | 2015-03-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
CN107249626A (zh) | 2015-02-19 | 2017-10-13 | 辉瑞大药厂 | 脑膜炎奈瑟球菌组合物及其方法 |
WO2017137085A1 (en) | 2016-02-11 | 2017-08-17 | Sanofi Pasteur | Meningitidis vaccines comprising subtilinases |
KR102567845B1 (ko) | 2017-01-31 | 2023-08-17 | 화이자 인코포레이티드 | 네이세리아 메닌기티디스 조성물 및 그의 방법 |
CA3059650C (en) * | 2017-05-10 | 2023-12-19 | Global Bioenergies | Improved methods for producing isobutene from 3-methylcrotonic acid |
WO2019018744A1 (en) | 2017-07-21 | 2019-01-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | IMMUNOGENIC COMPOSITIONS OF NEISSERIA MENINGITIDIS |
US20220081707A1 (en) * | 2018-07-25 | 2022-03-17 | The Trustees Of Indiana University | Diagnostic assay for a strain of neisseria meningitidis |
CN113136444B (zh) * | 2021-05-10 | 2024-04-19 | 临沂大学 | 医用食品中海氏肠球菌的微滴数字pcr检测方法 |
CN116162140A (zh) * | 2022-07-19 | 2023-05-26 | 四川大学华西医院 | 一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE912559A1 (en) * | 1990-07-19 | 1992-01-29 | Merck & Co Inc | The class ii protein of the outer membrane of neisseria¹meningitidis, and vaccines containing same |
CA2047043A1 (en) * | 1990-07-19 | 1992-01-20 | Allen I. Oliff | Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties |
IL98839A0 (en) * | 1990-07-19 | 1992-07-15 | Merck & Co Inc | Vaccines comprising protein of the outer membrane of neisseria meningitidis |
US6472518B1 (en) * | 1996-10-24 | 2002-10-29 | Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services | Invasion associated genes from Neisseria meningitidis serogroup B |
JP2004511201A (ja) * | 1998-10-09 | 2004-04-15 | カイロン コーポレイション | ナイセリアゲノム配列およびそれらの使用方法 |
-
2000
- 2000-03-08 BR BR0010361-6A patent/BR0010361A/pt not_active Application Discontinuation
- 2000-03-08 EP EP05075284A patent/EP1605061A1/de not_active Ceased
- 2000-03-08 DK DK00910392T patent/DK1185691T3/da active
- 2000-03-08 WO PCT/US2000/005928 patent/WO2000066791A1/en active IP Right Grant
- 2000-03-08 ES ES00910392T patent/ES2323845T3/es not_active Expired - Lifetime
- 2000-03-08 CA CA002371032A patent/CA2371032A1/en not_active Abandoned
- 2000-03-08 EP EP00910392A patent/EP1185691B1/de not_active Expired - Lifetime
- 2000-03-08 CN CNA2007100037383A patent/CN101033467A/zh active Pending
- 2000-03-08 CN CN00809820A patent/CN1359426A/zh active Pending
- 2000-03-08 DE DE60042114T patent/DE60042114D1/de not_active Expired - Lifetime
- 2000-03-08 MX MXPA01011047A patent/MXPA01011047A/es active IP Right Grant
- 2000-03-08 AT AT00910392T patent/ATE430207T1/de active
- 2000-03-08 JP JP2000615413A patent/JP2003527079A/ja active Pending
- 2000-03-08 AU AU32492/00A patent/AU780308B2/en not_active Ceased
-
2007
- 2007-02-26 US US11/711,740 patent/US20070219347A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU3249200A (en) | 2000-11-17 |
MXPA01011047A (es) | 2003-10-14 |
CA2371032A1 (en) | 2000-11-09 |
EP1185691B1 (de) | 2009-04-29 |
AU780308B2 (en) | 2005-03-17 |
ATE430207T1 (de) | 2009-05-15 |
BR0010361A (pt) | 2003-06-10 |
ES2323845T3 (es) | 2009-07-27 |
US20070219347A1 (en) | 2007-09-20 |
WO2000066791A1 (en) | 2000-11-09 |
JP2003527079A (ja) | 2003-09-16 |
CN1359426A (zh) | 2002-07-17 |
EP1605061A1 (de) | 2005-12-14 |
EP1185691A1 (de) | 2002-03-13 |
CN101033467A (zh) | 2007-09-12 |
DE60042114D1 (de) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1185691T3 (da) | Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf | |
MXPA01003557A (es) | Secuencias genomicas de neisseria y metodos para su uso. | |
DK1645631T3 (da) | Neisseria antigener og præparater | |
CY1114333T1 (el) | Αντιγονα του neisseria meningitidis | |
CY1110880T1 (el) | Αντιγονα neisserial | |
DK1385876T3 (da) | Gonococcusproteiner og nukleinsyrer | |
CY1109268T1 (el) | Αλληλουχιες γονιδιωματος της neisseria και μεθοδοι για την χρηση τους |